Andere Sprachen Shanghai Kehua Bio-Engineering Co.,Ltd

Aktien

002022

CNE000001KC9

002022

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 31.05.2024			% 5 Tage	% 1. Jan.
6,66 ^CNY	+2,15 %		-2,49 %	-41,48 %

28.04.	Shanghai Kehua Bio-Engineering Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
22.03.	Shanghai Kehua Bio-Engineering Co.,Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	28.04.
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	22.03.
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Board Elections	21.03.
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit	05.03.
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.	29.02.
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit	19.02.
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.	29.10.23
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.	27.10.23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27.10.23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	16.08.23
Shanghai Kehua Bio-Engineering Registers Hepatitis Detection Kit	14.08.23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments	29.06.23
Kehua Bio-Engineering Registers Diagnostic Reagent	22.06.23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 10 May 2023	28.04.23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	21.04.23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for 2022	18.04.23
Kehua Bio-Engineering Registers Tumor Necrosis Testing Kit	06.04.23
Shanghai Kehua Bio-Engineering Co.,Ltd Proposes Final Cash Dividend for the Year 2022	23.03.23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	22.03.23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Shanghai Kehua Bio-Engineering Co.,Ltd

Aktien

002022

CNE000001KC9

002022

Andere Sprachen

Filter